1 results match your criteria: "Department of Hematology and Oncology-MedStar Washington Cancer Institute[Affiliation]"
Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases.
JAAD Case Rep
September 2020
Department of Hematology and Oncology-MedStar Washington Cancer Institute, Washington, District of Columbia.